Log in or Sign up for Free to view tailored content for your specialty!
Hepatology News
New approach needed to manage adults with colorectal cancer, fatty liver
Proteins and genetic material secreted by fatty liver cells stimulate the spread of colorectal cancer to the liver, study results published in Cell Metabolism showed.
EASL Congress 2023 rewind: What you may have missed; alcohol use, NASH data top agenda
EASL Congress 2023 has ended but, as the society’s official media partner, Healio was at the forefront covering the latest in liver disease. Wondering what you may have missed? Healio recaps the biggest news disrupting the specialty.
Log in or Sign up for Free to view tailored content for your specialty!
CDC recommends single-visit testing for hepatitis C
In new guidance, the CDC recommended that the two-step testing process for hepatitis C virus be completed in one visit, eliminating the need for multiple visits, which often leads to incomplete testing.
Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis
Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data presented at EASL Congress.
Malpractice insurance is a physician’s first line of defense
Concerns about potential malpractice liability are top of mind for many physicians of all specialties. This is not surprising given recent verdicts in medical malpractice actions that have awarded millions of dollars in damages to plaintiffs.
Lowering HCC incidence threshold in guidelines cost-effective, may improve early detection
Research demonstrated that hepatocellular carcinoma surveillance is cost-effective at a lower incidence threshold of 0.7% in virologically cured patients with hepatitis C virus, underscoring the need to update clinical guidelines.
Time-restricted eating may be ‘promising management option’ in patients with NAFLD, NASH
Modifying the timing of daily energy intake may improve metabolic health and restore natural circadian rhythms among patients with nonalcoholic fatty liver disease, according to a review published in Gut.
Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals
Nearly 75% of patients with end-stage liver disease in safety-net hospitals were not referred for liver transplant evaluation, mostly due to active alcohol use or insurance issues, according to data published in JAMA Network Open.
BLOG: Corporate practice of medicine prohibitions
Many states have corporate practice of medicine prohibitions.
1 in 10 patients with advanced liver disease develops liver-related event after HCV cure
The risk for hepatic decompensation and hepatocellular carcinoma remained constant after hepatitis C virus cure among patients with advanced chronic liver disease, underscoring the need for post-HCV risk stratification in the long term.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read